Samala, G., Nallangi, R., Devi, P., Saxena, S., Yadav, R., Sridevi, J., … Sriram, D. (2014). Identification and development of 2-methylimidazo 1,2-a pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 22(15), 4223-32. https://doi.org/10.1016/j.bmc.2014.05.038 (Original work published 2014)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Saxena, S., Renuka, J., Jeankumar, V., Yogeeswari, P., & Sriram, D. Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Saxena, S., Renuka, J., Yogeeswari, P., & Sriram, D. (2014). Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation. Molecular Informatics, 33(9), 597-609. https://doi.org/10.1002/minf.201400058

Devi, P., Samala, G., Sridevi, J., Saxena, S., Alvala, M., Salina, E., … Yogeeswari, P. (2014). Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. ChemMedChem, 9(11), 2538-47. https://doi.org/10.1002/cmdc.201402171

Jeankumar, V., Renuka, J., Kotagiri, S., Saxena, S., Kakan, S., Sridevi, J., … Sriram, D. (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035

Saxena, S., Devi, P., , Yogeeswari, P., & Sriram, D. (2014). Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening. Journal of Molecular Graphics & Modelling, 47, 37-43. https://doi.org/10.1016/j.jmgm.2013.08.005

Kumar, V. J., Poyraz, O., Saxena, S., Schnell, R., Yogeeswari, P., Schneider, G., & Sriram, D. (2013). Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening. Bioorganic & Medicinal Chemistry Letters, 23(5), 1182-6. https://doi.org/10.1016/j.bmcl.2013.01.031 (Original work published 2013)

Poyraz, O., Jeankumar, V., Saxena, S., Schnell, R., Haraldsson, M., Yogeeswari, P., … Schneider, G. (2013). Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 56(16), 6457-66. https://doi.org/10.1021/jm400710k (Original work published 2013)